Quarterly report pursuant to Section 13 or 15(d)

Subsequent Event - Narrative (Details)

v3.19.2
Subsequent Event - Narrative (Details)
$ in Millions
Jul. 23, 2019
USD ($)
Ab Initio Biotherapeutics, Inc. | Subsequent Event  
Subsequent Event [Line Items]  
Consideration transferred in acquisition $ 12.0